Analyst Ratings for Emergent Biosolutions Inc. (EBS)

Updated: 2017-07-27

Analysts covering Emergent Biosolutions Inc. (NYSE:EBS) have given it a consensus rating of Buy. A consensus rating of Buy was previously issued for EBS last month.

A buy rating was issued by 5 analysts, 0 gave an overweight rating, 1 gave a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Several price targets were given for EBS by the analysts covering the stock. The maximum price target given was 50, implying potential capital gains of 38.7 percent. The lowest price target was 33, implying potential capital losses of -8.46 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. That number becomes -33.43 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 4.29 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

EBS has an estimated earnings growth rate of 27.19 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. EBS has a PEG ratio of 1.11.

EBS has traded between a high of 36.64 and a low of 24.47 over the past year. Currently the stock is 47.32 percent higher than its low, and below the high by 1.61 percent. EBS has a P/E ratio of 30.31. Investors typically compare the P/E ratio to a company's peers in the industry. The EBS value stock report compares EBS to some of its peers using value stock charts. The market cap of EBS is $1.48 billion. EBS will post this quarters earnings in days, on 0000-00-00.